The identification of a human ribosomal protein L9 (hRPL9) cDNA as a sequence capable of suppressing the lethal effects of heterologously expressed murine Bax in yeast led us to investigate its antiapoptotic potential. Using growth and viability assays, we show that yeast cells heterologously expressing hRPL9 are resistant to the growth inhibitory and lethal effects of exogenously supplied copper, indicating that it has pro-survival properties. To explore potential mechanisms, we used yeast mutants defective in all three types of programmed cell death (apoptosis, necrosis, and autophagy). The ability to retain pro-survival function in all the mutants suggests that hRPL9 may regulate a common pro-death process. In contrast, the yeast RPL9 orthologues, RPL9A and RPL9B, have opposite effects when overexpressed in yeast. In effect, instead of showing resistance to stress, RPL9A and RPL9B overexpressing cells show reduced cell growth. Further analysis indicates that the effects of overexpressed RPL9A and RPL9B are not in themselves lethal, instead, they serve to increase cell doubling time. Thus, yeast RPL9s are more representative of RPs whose extra-ribosomal function is similar to that of tumor suppressors. Taken together, our results demonstrate that RPL9 represents a species-and sequence-specific regulator of cell growth and survival.
Introduction
Ribosomes are elaborate ribonucleotide protein complexes that mediate the process of translating mRNAs into proteins (Brodersen & Nissen, 2005) . They therefore represent a key regulatory point in the central dogma of biology consisting of self-replicating DNA to RNA to protein. Ribosome biogenesis is a highly regulated process that involves the stoichiometric assembly of, in eukaryotic cells, as many as 84 different ribosomal proteins and four ribosomal RNAs into the well-known functional small (40S) and large (60S) subunits (Wool et al., 1995; Korobeinikova et al., 2012) . A great deal of exceptional work has served to identity the sequential assembly of individual rRNAs and RPs into functional ribosomes (Lempiainen & Shore, 2009; Teng et al., 2013) . Their importance is in part reflected in their abundance, in the large amount of resources dedicated to their synthesis, as well as in the complex mechanisms involved in regulating ribosome assembly and subsequent role in translating mRNA into protein (Warner, 1999; Lempiainen & Shore, 2009; Teng et al., 2013) .
Although less well studied, individual components of ribosomes, including a large number of different ribosomal proteins, have been shown to have alternative functions that are distinct from their role in the ribosome (Warner & McIntosh, 2009; Bhavsar et al., 2010) . For example, in many species including yeast and human, ribosomal protein S3 can bind to an intron present within its own pre-mRNA and serve to prevent splicing. This process thus serves as a negative feedback mechanism to prevent the accumulation of excess RPS3 (Gao & Hardwidge, 2011) . In addition, to regulating gene expression, the extra-ribosomal functions of many ribosomal proteins involve regulating growth and cell survival (Teng et al., 2013) . For example, human RPL35a was identified as an antiapoptotic sequence that prevents cell death in response to multiple stresses (Lopez et al., 2002) . There are many other ribosomal proteins that have been demonstrated to be associated with cell survival. For example, overexpression of RPL3 and RPS29, respectively, leads to growth inhibition and the induction of cell death (Khanna et al., 2003; Shenoy et al., 2012; Russo et al., 2013) .
There are numerous difficulties associated with the study of the extra-ribosomal function of ribosomal protein genes. These include the fact that the loss of function of many RP genes leads to a loss of functional ribosomes. Accordingly, it often remains difficult to dissociate ribosomal from extra-ribosomal function for individual ribosomal proteins (Warner & McIntosh, 2009 ). We previously reported the identification of a number of novel pro-survival sequences by screening mammalian cDNA expression libraries in the yeast Saccharomyces cerevisiae undergoing Bax-mediated cell death (Yang et al., 2006; Clapp et al., 2012a) . One of the unreported cDNAs identified in our Bax screen encodes human ribosomal protein L9 (hRPL9). Given that yeast has proven to be a highly amenable system for the functional study of mammalian regulators of programmed cell death (PCD) and for the genetic analysis of RP-encoding genes, we reasoned that a more in-depth study of hRPL9 in yeast may be useful in characterizing potential antiapoptotic properties of ribosomal proteins (Carmona-Gutierrez et al., 2010; Clapp et al., 2012a; Steffen et al., 2012) .
Materials and methods

Yeast strains and plasmids
The S. cerevisiae BY4742 (MATa his3D1 leu2D0 lys15D0 ura3D0) strain was used throughout this study (EURO-SCARF) . All the mutants used were isogenic to BY4742 and were obtained from Thermo Scientific. Plasmids containing the cDNAs for Bh80 and 14-3-3 expressed under the control of the galactose-inducible GAL1 promoter in pYES-DEST52 were isolated in our previously described Bax screen (Yang et al., 2006) . The plasmids for the galactose-inducible expression of the yeast RPL9A and RPL9B on a URA3 yeast selectable marker were obtained from Thermo Scientific. A cDNA plasmid expressing an activated form of mouse Bax under the regulation of the yeast GAL1 promoter with a HIS3 selectable marker was previously described (Yang et al., 2006) .
Yeast transformations and growth
Yeast cells transformed with the different plasmids were selected for and maintained by the omission of the appropriate nutrient (Adams et al., 1997) . In some cases, rich media consisting of 2% Bacto peptone, 1% yeast extract, and 2% glucose was used (YEPD). Yeast cells were routinely grown in synthetic minimal media containing yeast nitrogen base (YNB) and 2% glucose with the required amino acids (aa) or bases. Glucose was replaced by 2% galactose and 2% raffinose to induce the expression of the sequences under the control of the GAL1 promoter.
Spot and viability assays
The spot assay was used to determine the ability of different transformants to grow in a variety of conditions (Clapp et al., 2012b) . Briefly, freshly saturated overnight cultures of the different yeast transformants were diluted in fresh, prewarmed galactose-containing media, incubated for 4 h to induce gene expression, serially diluted fivefold into sterile water, and 10 lL aliquots of the dilutions were spotted onto nutrient agar media containing different supplements as indicated in the figures. A minimum of three different spot assays with similar results were performed. For a direct measure of viability, freshly inoculated galactose-growing cultures of the different transformants were challenged with different concentrations of copper sulfate (1-2 mM) and allowed to grow at 30°C for 18 h. Aliquots of the cultures were removed, and viability was determined by microscopic examination of cells stained with the vital dye trypan blue (0.1%) (Williams et al., 2011) . At least three different samples of 100 cells were scored for each experiment, and the experiments were repeated at least three independent times. For the clonogenicity assay, a varying number of cells, 300 for untreated to 30 000 from the 1.4 mM copper-treated cultures, were plated onto YEPD and incubated for 48 h. Viability is reported as the percentage of cells which formed visible colonies. The experiment was carried out in triplicate and repeated three times.
Results and discussion
Identification of human ribosomal protein L9 as a novel Bax suppressor Bh109 represents a 707 nt human cDNA that was previously isolated in our functional screen looking for sequences that could prevent Bax-mediated cell death in yeast (Yang et al., 2006) . We first set out to confirm that Bh109 could prevent the lethal effects of Bax in yeast. Wild-type BY4742 yeast cells were re-transformed with the B109 cDNA with and without a plasmid expressing murine Bax. As a control, we also transformed yeast cells with a plasmid expressing a human 14-3-3 cDNA that represents a previously isolated Bax suppressor that also serves to prevent apoptotic-like PCD in yeast (Clapp et al., 2012b) . Freshly saturated glucose-grown cultures of the different transformants were serially diluted and aliquots were spotted onto nutrient agar plates with glucose or with raffinose and galactose. Both the Bax and the Bax suppressors are expressed under the control of the yeast GAL1 promoter, and therefore, the glucose plates serve as control to demonstrate that equal amount of cells was used in the spot assays (Fig. 1, left panel) . When grown on galactose-containing media, cells harboring the Bax-expressing plasmid show reduced growth that is indicative of the lethal effects of Bax expression in yeast (Kissova et al., 2006) . In contrast, cells co-expressing 14-3-3 or Bh109 show enhanced growth indicative that the expression of these clones confers resistance to the effects of Bax (Fig. 1, right panel) . Analysis of the Bh109 DNA sequence in GenBank database using BLAST revealed that it is identical to a 712 nt cDNA containing the coding sequence for the 192 residues of human ribosomal protein L9 (hRPL9) (GenBank accession number BC000483). Bh109 contained the entire coding sequence (nt 7-585) as well as 24 nt of poly A tail at its 3′ end. The possibility that hRPL9 may be cytoprotective is not surprising given that numerous ribosomal proteins are known to have alternative functions that are distinct from their role in the ribosome (Warner & McIntosh, 2009; Bhavsar et al., 2010) . Further, many RPs have been implicated as regulators of cell growth, survival, and death (Lopez et al., 2002; Ahn et al., 2013; Teng et al., 2013) .
Human ribosomal protein L9 prevents copperinduced lethality
Although it prevents the effects of Bax, we were interested in determining whether RPL9 could serve as a general regulator of stress-mediated cell death. We therefore examined the ability of RPL9 to prevent cell death in response to copper, a known initiator of apoptotic cell death in yeast (Liang & Zhou, 2007) . We set out to determine, using the spot assay, the conditions in which copper could be used for this purpose. The growth of yeast transformants harboring control empty vector (vector) or cDNA-expressing plasmids for 14-3-3 (14-3-3), ribosomal protein L9 (hRPL9), or an uncharacterized Bax suppressor (Bh80) was assessed using the spot assay. Freshly saturated cultures were serially diluted and spotted onto nutrient agar media containing glucose, galactose, or galactose with increasing concentrations of copper sulfate (CuSO 4 ). There is no difference in the growth of cells grown on galactose or glucose media (Fig. 2a) . With increasing concentrations of copper (1.8-2.2 mM), there was gradual decrease in the growth of control cells (vector) with very little growth detected at 2.2 mM copper (Fig. 2a) . In contrast, cells expressing human RPL9 as well as 14-3-3 and Bh80 showed enhanced growth in all concentrations of copper used when compared to the empty vector cells.
It remains that hRPL9 may not be preventing cell death, it may instead serve to promote the growth of stressed cells. To address this, we grew the different transformants in liquid media and determined cell viability after 18 h in the presence of copper. Using microscopical examination of cells stained with the vital dye trypan blue, it was determined that the viability of control cells (vector) was decreased to 31.0 AE 3.2% (Fig. 2b ). In contrast, the viability of cells expressing the known antiapoptotic sequence 14-3-3 or hRPL9 was only modestly decreased to 87% and 80%, respectively (Fig. 2b) . Taken together, these results suggest that like 14-3-3, hRPL9 represents a pro-survival and likely antiapoptotic sequence Clapp et al., 2012b) . It should be noted that slightly higher concentrations of copper (6 mM) were previously used to induce apoptosis (Liang & Zhou, 2007) . This likely reflects the fact that a shorter time of exposure to copper (18 h) and different growth media were used. Not only is the intensity of the stress important but the time of exposure to any given stress will dictate a cell's response Milisav et al., 2012) . As an independent test of the effects of hRPL9, we also used the clonogenicity assay to monitor viability. As reported previously, viability is decreased with using this assay because a proportion of cells that do not stain with the vital dye after a given stress, here 18 h of copper, do not stain with the vital and appear alive, but they nevertheless have initiated the process of cell death and are unable to form a colony (Yang et al., 2006) . Here, we find that the viability of control cells harboring empty vector was decreased to 0.12 AE 0.012% after 18 h treatment with 1.4 mM copper. In contrast, the viability was increased over 20-fold for cells expressing human 14-3-3 (3.1 AE 0.6%) and for cells expressing (Yang et al., 2006) . Plasmid DNA from the original Bax-resistant cell containing Bh109 was retrieved from yeast, purified, and re-introduced into naive BY4742 yeast cells with and without Bax. As a control, a plasmid expressing the previously characterized Bax suppressor 14-3-3 was included as a positive control (Clapp et al., 2012b) . Cultures of doubly transformed yeast cells were serially diluted, and aliquots were spotted onto glucose or galactose media, and photographs of the resultant plates are shown after 5 days of incubation at 30°C. hRPL9 (3.2 AE 0.8%). The pro-survival effects of human RPL9 observed here suggest that this sequence joins the group of other human RP genes, including RPL35a and RPS3, as having antiapoptotic properties (Lopez et al., 2002; Ahn et al., 2013) .
The mechanism by which RPs can regulate cell growth in general or how they mediate antiapoptosis is not currently known (Teng et al., 2013) . They do not have any properties of conventional antiapoptotic proteins including enzymes that reduce the levels of pro-apoptotic second messengers such as ROS, calcium, iron, dUTP, or ceramide (Fulda, 2009; Portt et al., 2011; Farrugia & Balzan, 2012; Ring et al., 2012) . RPs are well known to be able to interact with numerous other proteins, so it remains that they may function as chaperones, many of which such as heat-shock proteins or 14-3-3 are well known for their ability to attenuate apoptotic responses . Further, many of the multifunctional extra-ribosomal roles of some RPs, such as RPS3, have been mapped to its ability to interact with a wide variety of different cellular proteins including a number of different protein kinases (Gao & Hardwidge, 2011) . Alternatively, it remains possible that human RPL9 promotes cell survival by a nonspecific process. Thus, although human and yeast RPL9 share 50% sequence identity, it remains that human RPL9 may have functional characteristics of other proteins when expressed at high levels in yeast. A BLAST search of the known yeast proteins identified several other proteins that share similarity to human RPL9. Unlike the similarity to yeast Rpl9 ps, the similarities are mostly limited to 30-40% identities over 100 amino acid stretches of the proteins. The most significant similarity is with a mitochondrial ribosomal protein of the large subunit encoded by MRPL6 (Graack & Wittmann-Liebold, 1998) . Human RPL9 may possibly function as a component of the mitochondrial ribosome where it may help in preventing mitochondrial-mediated PCD. Other similarities were found with Asf2p, which is described as an antisilencing protein that causes derepression of silent yeast mating loci when overexpressed (Le et al., 1997) as well as a mitochondrial-localized protein of unknown function (YJR039Wp). The availability of yeast mutant strains lacking these potential interactors should facilitate the examination of their potential role in mediating the prosurvival effects of hRPL9 in yeast. In effect, the similarity between yeast proteins and the previously identified Bax After 18 h, samples were taken, treated with the vital dye trypan blue, and percentage of live cells (% trypan blue negative) was determined by microscopical examination. Data are mean AE SD of triplicate experiments that were repeated a minimum of three times. *The viability is significantly different than control vector cells using Student's t-test (P > 0.001).
suppressor TSC22 was used as the basis to identify a novel antiapoptotic motif that was also discovered in functionally unrelated yeast Sno1p and Fyv10p (Khoury et al., 2008) .
Analysis of the protective effects of human ribosomal protein L9 in PCD mutants
Our results suggest that hRPL9 is capable of preventing PCD in response to apoptosis-inducing stimuli. In addition to apoptosis, there are two other major forms of PCD namely necrosis and autophagy . Because Bax is known to induce cell death that has features of all three forms of PCD, it remains that Bax suppressors may serve to prevent any or multiple forms of PCD (Manon et al., 1997; Kissova et al., 2006) . In an effort to examine potential relationship between hRPL9 and all forms of PCD, we analyzed the ability of RPL9 to prevent cell death in a variety of yeast mutants defective in key genes of all three major pathways (Carmona-Gutierrez et al., 2010). For apoptotic cell death, we used yeast cells lacking MCA1D and yBH3D. MCA1 (or YCA1) is a metacaspase that has caspase-like functions in yeast (Madeo et al., 2002) . yBH3 contains a single BH3 domain that is characteristic of the Bcl-2 single Bh3-containing family of apoptotic regulators and appears to have proapoptotic functions in yeast (Buttner et al., 2011) . For necrosis, yeast cells lacking VMA3D and CPR3D were chosen. VMA3 is a subunit of the vacuolar proton-translocating ATPase (V-ATPase) complex involved in the acidification of vacuoles, and mutants lacking this proteins show increased sensitivity to oxidative stress but also increased resistance to necrosis (Milgrom et al., 2007; Kim et al., 2012) . CPR3 encodes a mitochondrial cyclophilin that is thought to be involved in mediating programmed necrosis responses (Zhang et al., 2006; Liang & Zhou, 2007) . Of importance is that the yeast CPR3 encodes part of the core component that corresponds to the mammalian permeability transition pore that is activated in necrosis. Finally, we used mutants lacking ATG1 and ATG7 to study autophagy. These genes encode critical proteins for autophagy, but they show no defects in normal growth (He & Klionsky, 2009 ). Cultures of wild type and mutant cells transformed with control empty plasmid (vector) or with the 14-3-3 or hRPL9-expressing plasmids were serially diluted and spotted on nutrient agar media with and without 2.0 mM copper sulfate. All the mutants, with the exception of VMA3D, showed similar growth on normal media indicating that there was no apparent growth defects associated with the loss of the genes (Figs 3-5). The expression of hRPL9 increased the growth of all the mutants examined in the presence of 2 mM copper. Thus, hRPL9 does not appear to require any of the genes examined to prevent the effects of copper. Of interest is the observation that many of the mutants examined, including MCA1D yBH3D and VMA3D, showed enhanced sensitivity to copper when compared to the wild-type cells (Figs 3-5) . These defects were, at least partially, corrected by the expression of hRPL9 or 14-3-3 suggesting that premature apoptosis is occurring (Figs 3-5 ). This suggests that the loss of certain pro-apoptotic genes may render cells more susceptible to Fig. 3 . Analysis of the effects of hRPL9 in apoptotic-deficient yeast mutants. Wild-type BY4742 (WT) or isogenic caspase (MCA1D) and BCL-2 homology domain containing gene (yBH3D)-deficient strains were transformed with empty vector, 14-3-3-, or hRPL9-expressing plasmids. Freshly grown cultures of the strains were serially diluted, and aliquots were spotted onto nutrient agar media without (control) and with copper sulfate (+CuSO 4 ). Photographs of the plates after incubation at 30°C are shown. chronic exposure to apoptotic stimuli. This is not surprising for the VMA3D mutant as these cells are previously been shown to have an increased sensitivity to many stresses (Milgrom et al., 2007) . The increased sensitivity observed for the MCA1D and yBH3D mutants may at first glance appear to be contradictory as the loss of such pro-apoptotic genes usually results in an increased resistance to PCD-inducing stresses . The situation for yBH3 is not so straightforward as this gene has been simultaneously described as a Bcl-2 motif containing pro-apoptotic protein (Buttner et al., 2011) as well as the yeast ortholog of the conserved antiapoptotic Bax inhibitor protein Bxi1 (Cebulski et al., 2011) . Thus, depending on the conditions examined, the yeast ORF known as YNL305C can be pro-or antiapoptotic, a situation that is not uncommon for many proteins involved in regulating PCD . Given that MCA1D has not been ascribed such a dual role, a more detailed Fig. 4 . Analysis of the effects of hRPL9 in necrosis-deficient yeast mutants. Wild-type BY4742 (WT) or isogenic mutants lacking a component of the vacuolar H(+)-ATPase (VMA3D) or the mitochondrial cyclophilin (CPR3D)-deficient strains were transformed with empty vector, 14-3-3-, or hRPL9-expressing plasmids. Freshly grown cultures of the strains were serially diluted, and aliquots were spotted onto nutrient agar media without (control) and with copper sulfate (+CuSO 4 ). Photographs of the plates are shown after 5 days of incubation at 30°C. Fig. 5 . Analysis of the effects of hRPL9 in autophagy deficient yeast mutants. Wild-type BY4742 (WT) or isogenic mutants unable to undergo autophagy due to the absence of a protein kinase (ATG1D) or a Ubiquitin-activating enzyme E1-like protein (ATG7D) were transformed with empty vector, 14-3-3-, or hRPL9-expressing plasmids. Freshly grown cultures of the strains were serially diluted, and aliquots were spotted onto nutrient agar media without (control) and with copper sulfate (+CuSO 4 ). Photographs of the plates are shown after 5 days of incubation at 30°C. analysis of the sensitivity of the MCA1D mutant was carried out using the spot growth assay and a range of copper concentrations. Even at 1.8 mM copper, there is a discernible decrease in the growth of the MCA1D mutant with no apparent effect on the isogenic wild-type strain (Fig. 6) . The effect of copper on the growth of the MCA1D mutant is even more pronounced at the higher concentrations of 1.9 and 2.0 mM and greater than what is observed with the wild-type cell (Fig. 6) . Similar results were observed when viability was directly measured using trypan blue. Viability of cells treated with 1.2 mM copper for 18 h was a respective 40 AE 3.3% and 24 AE 2.9% for the wild type and the MCA1D mutant. The reversal of this effect in cells overexpressing the previously characterized antiapoptotic 14-3-3 sequence suggests that copper is inducing a programmed form of cell death in both strains (Fig. 6 ). Despite the increased sensitivity to copper, the MCA1D mutant retained its hallmark increased viability in response to prolonged periods of stationary phase (Madeo et al., 2002) . In effect, viability using trypan blue was found to decrease to 12.3 AE 3.2% for wild-type cells compared to and 37 AE 4.1% the MCA1D mutant after 14 days in stationary phase. The type of cell death in this yeast aging model differs from other forms of PCD in at least one other way as we have not been able to find any Bax suppressor, including 14-3-3 and hRPL9, which are capable of delaying this form of PCD (Williams et al., 2011; Breitenbach et al., 2012) . Although MCA1 has been implicated in mediating the effect of many stresses, it remains that it is not involved in all stress responses (Guaragnella et al., 2011) . Our results are in line with these and other studies suggesting that the complexity and the functional diversity of MCA1 is still being elucidated (Lee et al., 2008; Wilkinson & Ramsdale, 2011) . The situation is reminiscent to what is observed with mammalian capsase3, a well-known executioner caspase that has other non-PCD functions such as its requirement for the final stages of myoblast development (Wang & Lenardo, 2000) .
As mentioned above, the mechanism by which RPL9 or other ribosomal proteins can prevent PCD is enigmatic. Our experiments using yeast mutants having defects in all three major forms of PCD, including apoptosis, necrosis and autophagy, suggests that hRPL9 does not specifically inhibit any one form of PCD (Figs 3-5 ). This is consistent with a model that many antiapoptotic proteins appear to function to decrease stress. For example, many sequences identified as Bax suppressors turn out to be able to prevent cell death in response to multiple stresses. For example, sphingomyelin synthase 1 (SMS1) appears to function as antiapoptotic sequence by virtue of its ability to utilize the pro-apoptotic ceramide sphingolipid as a substrate when synthesizing sphingomyelin (Tafesse et al., 2006; Yang et al., 2006) . In spite of this, SMS1 is capable of preventing Bax-and ROS-mediated PCD. Other antiapoptotic sequences including ROS scavengers and dUTP hydrolyzing enzyme can also prevent cell death in response to a variety of stresses including Bax (Moon et al., 2002; Williams et al., 2011; Penades et al., 2013) . Very little is currently known about the mechanisms responsible for the cross-talk that occurs between the different antiapoptotic and pro-survival pathways (Zdralevic et al., 2012) . Well-known examples include the ability of one stress such as heat to induce the resistance to a completely different stimulus such as oxidative stress (Pallepati & Averill-Bates, 2010; Hou et al., 2013) . More recently, the inhibition of TRAIL receptor-activated caspase 8 was shown to be sufficient to switch an apoptotic response to a necroptotic-like response (Weinlich et al., 2011) . We believe that hRPL9 functions at point that we have previously discussed as being located somewhere between the actual stress and the activation of Bax and increases in the levels of pro-apoptotic second messengers such as ROS and ceramide .
RPL9A and RPL9B inhibit growth
Yeast contains two distinct genes that code for the ribosomal protein L9. RPL9A and RPL9B both encode for proteins of 191 residues that share 97% sequence identity (Planta & Mager, 1998) . Sequence alignment of hRPL9 with the sequence of the yeast proteins demonstrates that they share a high degree of similarity with the 192 residue human protein sharing 50% sequence identity with its yeast orthologues (not shown). To determine whether the yeast RPL9 proteins are also cytoprotective, we transformed wild-type yeast with plasmids expressing either yeast RPL9A or RPL9B under the control of the GAL1 promoter. Cultures of yeast cells harboring these plasmids as well as plasmids expressing 14-3-3 or hRPL9 were serially diluted and spotted on nutrient agar media with glucose or with galactose and lethal levels of copper. All transformants show similar growth on glucose noninducing media (Fig. 7) . In contrast, cells expressing hRPL9 or 14-3-3 show enhanced growth, while cells expressing either yeast RPL9A or RPL9B show reduced growth on the copper plates when compared to empty vector control cells (Fig. 7) . This suggests that the overexpression of the yeast RPL9A or RPL9B genes do not confer cell survival instead they serve to inhibit growth or induce cell death. These results suggest that yeast RPL9A or RPL9B sequences are like many other RPs that have been shown to lead to growth defects, cell cycle arrest, and apoptosislike PCD when overexpressed (Bhavsar et al., 2010) . Alternatively, it remains possible that the effects of the yeast RPL9 genes expressed under the control of the strong GAL1 promoter may be due to cytotoxicity brought upon by the high levels of expression induced by the addition of 2% galactose (Mumberg et al., 1994) . We reasoned that reduced expression would decrease the toxicity and allow us to examine whether the yeast RPL9A may also have cytoprotective properties. This does not appear to be the case as reduced growth could still be observed in cells growing on reduced levels of galactose (0.1%) (Fig. 8, top panel) , a condition that has been shown to reduce the expression of genes under the control of the GAL1 promoter (Mumberg et al., 1994) . It remains that the expression of the GAL1 may be reduced due to an early depletion of galactose. Nevertheless, what is clear is that even at very low levels, induction of the expression of yeast RPL9A is sufficient to observe growth inhibitory effects.
The effects of overexpressing RPL9A may be due to a steric hindrance-type inhibitory effect on ribosome biogenesis and subsequent decrease in the levels of functional ribosomes. If this is true, we reasoned that these cells should be overly sensitive to a further decrease in their ability to carry out protein synthesis. As an indirect test of this, we examined the effects of different concentrations of Fig. 7 . Effect of overexpressing yeast RPL9A or RPL9B on yeast growth. Wild-type BY4742 (WT) was transformed with empty vector (vector), 14-3-3-, hRPL9-, RPL9A-, or RPL9B-expressing plasmids. Freshly grown cultures of the strains were serially diluted, and aliquots were spotted onto nutrient agar media without (control) and with copper sulfate (+CuSO 4 ). Photographs of the plates are shown after 5 days of incubation at 30°C. Both strains grew the same on glucose-containing media, while the induction of the expression of RPL9A by the inclusion of 0.1% galactose was once again shown to be sufficient to cause a reduction in cell growth compared to cells containing empty vector alone (Fig. 8) . Growth in the presence of increasing concentrations of cycloheximide, from sublethal to growth inhibitory levels, caused a reduction in the growth of RPL9A-expressing cells that was similar to control cells (Fig. 8) . There are indications that altered levels of ribosomal proteins may lead to increases in some forms of stresses such as ER stress (Steffen et al., 2012) . We thus carried out the same experiment using the ER stress inducer dithiothreitol (DTT). Similar results were obtained with increasing concentrations of DTT as observed with cycloheximide (Fig. 8) . These results suggest that RPL9A-overexpressing cells do not show decrease in protein synthesis capacity or an increase in ER stress. This is in contrast to our results obtained with copper, where copper stress and expression of RPL9A show a synergistic negative effect on the growth of yeast (Fig. 7) . This suggests that RPL9A may simply represent a stress similar to copper and serve to induce a form of PCD in yeast.
Overexpression of yeast RPL9 sequences in PCD-defective mutants
Our previous results showing an additive growth inhibitory effect of copper and overexpression of RPL9 suggest that they may represent two distinct types of stresses that activate different PCD pathways. This concept has a multitude of precedents; for example, copper and manganese have been reported to activate different pathways in spite of the apparent similarity to both stresses (Liang & Zhou, 2007) . This opens up the possibility that we may be able to identify conditions in which RPL9A lose their toxicity. We thus examined the toxicity as well as potential cytoprotective effects of yeast RPL9s by overexpressing RPL9A in strains defective in different PCD pathways using a subset of the yeast mutants that we described above (Figs 3-5 ). Here we have included representative mutants that are lacking YBH3D, ATG1D, and CPR3D that are respectively defective in apoptosis, autophagy, and necrosis (Fig. 9) . Cultures of the different mutants as well as wild-type cells transformed with empty vector, hRPL9, or RPL9A were serially diluted and simultaneously spotted on three different types of nutrient media agar. All the transformants showed identical growth when spotted on Fig. 9 . Analysis of the effects of RPL9A or RPL9B on the growth of PCD-deficient mutants. Wild-type BY4742 (WT) or isogenic mutants lacking the yeast caspase (MCA1D), the Bcl-2 homology domain containing gene yBH3D, a component of the vacuolar H(+)-ATPase (CMA3D), the mitochondrial cyclophilin (CPR3D), the autophagy protein kinase (ATG1D), a ubiquitin-activating enzyme (ATG7D), or the spermine synthase (SPE4D) were transformed with empty vector, 14-3-3-or hRPL9-expressing plasmids. Freshly grown cultures of the strains were serially diluted, and aliquots were spotted onto nutrient agar media with glucose alone (control), with 2% raffinose and 0.1% galactose (0.1% GAL + 2% RAF) alone, or with copper sulfate (+CuSO 4 ). Photographs of the plates after incubation at 30°C are shown.
glucose-containing noninducing media (Fig. 9) . The effect of inducing low levels of expression of RPL9A using 0.1% galactose is sufficient to observe a small but reproducible growth inhibition of these cells. The addition of copper to cells growing with 0.1% galactose causes growth inhibition of all the mutants and the wild-type cells with the empty vector. As previously documented above (Figs 3-5) , the expression of hRPL9 conferred the ability to grow in the presence of copper for all the strains tested (Fig. 9) . Under these conditions, the overexpression of RPL9A did not confer the ability to grow in the presence of copper for all the PCD-defective mutants tested (Fig. 9) . These results suggest that the cytotoxic effects of RPL9A and possible cytoprotective effects, if they both exist, are not easily dissociable.
The polyamines, spermidine and spermine, are ubiquitous metabolites found in all eukaryotic cells that are known to play important roles in the regulation of growth and cell death (Minois et al., 2011) . For example, an increase in the levels of spermidine may mediate the antiapoptotic effects of certain stimuli as observed for the red wine longevity compound revesteranol (Eisenberg et al., 2009) . On the other hand, spermine accumulation has been reported as triggering apoptosis (Gill & Tuteja, 2011) . Spermidine is produced by the conversion of putrescine by the product of the SPE2 gene (S-adenosylmethionine decarboxylase), while the SPE4 gene product (spermine synthase) uses spermidine as a substrate to produce spermine (Gill & Tuteja, 2011) . Yeast cells lacking SPE2 require exogenous spermidine to grow aerobically, while the cells lacking SPE4 show no major phenotypic defect (Minois et al., 2011) . Hence, we made use of a yeast SPE4D mutant to examine the possibility that stress may induce PCD by increasing the levels of spermine and that antiapoptosis sequences may promote viability by decreasing the levels of spermine. We used the spot assay to assess to evaluate the mutant. There is very little difference in the growth in the presence of copper for the SPE4D and wild-type cells that are transformed with the empty vector (Fig. 9) . Similarly, the ability of hRPL9 expression caused similar protection against the effects of copper in both the wild type and the SPE4D mutant (Fig. 9) . On the other hand, the low level of RPL9A failed to prevent the effects of copper in the SPE4D mutant. Spermine therefore does not appear to have a role in mediating the effects of copper, hRPL9, or RPL9A.
Growth inhibition accounts for all the effects of RPL9A and RPL9B
A decrease in the growth of yeast cells on nutrient agar media may be due to the induction of PCD or to the inhibition of cell growth or a combination of both. Given that there are RPs that inhibit growth and others that can induce apoptosis (Lopez et al., 2002; Ahn et al., 2013; Teng et al., 2013) , we sought to determine what are the mechanisms responsible for the effects of overexpressing RPL9A and RPL9B in yeast. Freshly saturated glucosegrown cultures of yeast cells transformed with control empty vector or with vectors expressing hRPL9, 14-3-3, RPL9A, and RPL9B were inoculated at low density into fresh media containing 2% galactose and incubated for several days at 30°C. Aliquots of cells were removed at intervals thereafter, and viability and cell density were determined. The viability of all transformants, determined by direct microscopical examination of cells stained with the vital dye, was equal to or greater than 96% in glucose-grown cells throughout the 48 h. Similarly, the viability for all the transformants also remained very high with over 95% of the cells remaining viable after 48 h of incubation in galactose media. In contrast, there was a noticeable difference in cell number between the different transformants. The cultures of control, hRPL9-, and 14-3-3-expressing cells had similar doubling time of 3.4 AE 0.3 h. There was, however, a noticeable difference in the growth rate with cells overexpressing RPL9A and RPL9B. These cells showed a significantly increased doubling time of 7.4 AE 0.8 h. Thus, RPL9A and RPL9B do not induce cell death instead they appear to uniquely function as negative regulators of growth.
Conclusions
Taken together, our results suggest that RPL9, like many other ribosomal proteins, has extra-ribosomal functions. In our case, human RPL9 appears to assist uncontrolled growth by promoting stress-mediated survival and is thus more like other antiapoptotic-encoding RP genes (Lopez et al., 2002; Ahn et al., 2013) . On the other hand, the yeast Rpl9ps appear to inhibit cell growth and may serve to prevent uncontrolled growth. Although these results may appear to be paradoxical, such apparently conflicting results have been observed with numerous other sequences involved in regulating PCD. For example, we previously isolated a cDNA of the human TSC22 D4 gene as a Bax suppressor (Khoury et al., 2007) . Other studies have shown that it is antiapoptotic when over expressed in cultured kidney cells, while it can act as tumor suppressor to assist in inhibiting growth when overexpressed in hematopoietic cells (Fiol et al., 2007; Homig-Holzel et al., 2011) . Other examples include the fact that the gene encoding the yeast BH3-containing protein called YNL305C has been identified as the pro-apoptotic yBH3 as well as the antiapoptotic BXI1 (Buttner et al., 2011; Cebulski et al., 2011) . Differences in functions are likely to do with the type and intensity of the stresses that are used to activate the different PCD pathways.
There are a number of ribosomopathies associated with defects in ribosome biogenesis (Freed et al., 2010; Teng et al., 2013) . For example, the heterozygous loss of function mutation in one of a number of different RP genes leads to a decrease in RP gene dosage and a corresponding decrease in levels of the RP protein. The decrease in RP levels is thought to be pathophysiological because it serves to decrease ribosome biogenesis which then results in a decrease in protein synthesis capacity (Cmejlova et al., 2006; Teng et al., 2013) . Surprisingly, there is a somewhat paradoxical increase in risk of cancer associated with the decrease levels of many ribosomopathies (Teng et al., 2013) . This is in spite of the fact that most cancers are associated with an increase in protein synthesis capacity. This suggests that defects due to the loss of RPs is complex and cannot simply be accounted for by the decrease in ribosome biogenesis (Teng et al., 2013) . Thus, a number of investigators have suggested that many RPs may have the extra-ribosomal function of being haplo-insufficient tumor suppressors (Marygold et al., 2007; Lai et al., 2009; Jaako et al., 2011) . Thus, it follows that many RP-encoding genes serve to inhibit cell cycle progression or prevent apoptosis when overexpressed. Given that the expression levels of many RPs are elevated in a number of tumors, it would appear that the regulation of RP gene expression represents if not a normal regulatory mechanism, at least a pathophysiological one.
Although similar phenotypes including loss of growth control are seen in transgenic/gene knockout animal models of ribosomopathies, these are time-consuming to generate given the large number of RP genes involved (Jaako et al., 2011) . A systematic evaluation of the role of the individual RP genes is being accomplished in more genetically amenable systems including fruit fly, zebra fish, and yeast (Marygold et al., 2007; Lai et al., 2009; Jaako et al., 2011; Steffen et al., 2012) . Of interest is the fact that there is also a great deal of genetic evidence for the importance of ribosomal proteins in the regulation of cell growth and survival in these model organisms (Marygold et al., 2007; Lai et al., 2009; Jaako et al., 2011; Steffen et al., 2012; Teng et al., 2013) .
Yeast is a particularly interesting organism when it comes to RP-encoding genes as most genes encoding ribosomal proteins are encoded by two separate genes in the haploid genome. In effect, there are two paralogous genes that encode for 59 of the 78 different yeast ribosomal proteins (http://ribosome.med.miyazaki-u.ac.jp/; Steffen et al., 2012) . Even though the paralogues are very similar with many having identical sequences, many individual genes of the two paralogues appear to have acquired extra-ribosomal functions. Analysis of RP loss of function in yeast suggests that many paralogues are involved in growth control and aging (Steffen et al., 2008 (Steffen et al., , 2012 . A systematic analysis of the RP-encoding genes in yeast has identified that only a small subgroup of 10 of a total 137 RP-encoding genes actually give rise to a noticeable growth defect when overexpressed in yeast (Yoshikawa et al., 2011) . The list consists of RPS14A, RPS14B, RPS16B, RPS22B, RPL15B, RPL23A, RPL41A, RPL41B and as we have observed here RPL9A and RPL9B (Yoshikawa et al., 2011) . The limited number of genes that cause growth defects suggests that this is not an artifact, but instead, there may be a regulatory role associated with a small subset of RP genes. This is supported by studies in other organisms. Given that there is an increasing understanding of the genes and pathways involved in mediating PCD, the ability to use the power of yeast genetics should be useful in delineating the mechanisms responsible for the protective effects of hRPL9 and the growth inhibitory effects of RPL9A and RPL9B (Carmona- Gutierrez et al., 2010; Ring et al., 2012) . The usefulness of yeast to study mammalian RPs in yeast is further supported by the recent observation that the mouse RP3, which is a known inhibitor of stress-mediated cell death in mammalian systems (Ahn et al., 2013) , has recently been shown to inhibit ER-type stress-mediated cell death in yeast (De Graeve et al., 2013) .
Finally, in the case of the RPL9 gene studied here, strains having a deletion in either RPL9A or RPL9B show no noticeable defect in growth, indicating that at a gross level, either one of these genes is sufficient to fulfill its function in ribosome biogenesis (Steffen et al., 2012) . In other organisms, RPL9 is haplo-insufficient for growth in fruit fly and zebra fish (Beyer et al., 2013) . Other studies also suggest that RPL9 may have important nonribosomal roles to play. For example, the loss of function of RPL9 in fission yeast leads to an increase in cellular flocculation (Li et al., 2013) . In mouse cells, the mammary tumor virus gag protein requires RPL9 to be efficiently transported to the nucleolus (Beyer et al., 2013) .
